Taipei, Taiwan IBT Management Corporation is the famous Corporate Investor, which was founded in 2001. The main department of described Corporate Investor is located in the Taipei. The fund was located in Asia if to be more exact in Taiwan.
The standard case for the fund is to invest in rounds with 9-10 partakers. Despite the IBT Management Corporation, startups are often financed by Sutter Hill Ventures, MPM Capital, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Taiwan Biotech, Prudence Venture Investment Corporation, Industrial Bank of Taiwan. In the next rounds fund is usually obtained by The Baupost Group, Temasek Holdings, Taiwan Biotech.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2013. This IBT Management Corporation works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2002.
Among the various public portfolio startups of the fund, we may underline Paratek Pharmaceuticals, Medinox, Medinox For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Therapeutics, Biopharma.
Related Funds
| Fund Name | Location |
| Ayrton Capital | Connecticut, United States, Westport |
| Global Blockchain | Canada, Ontario, Toronto |
| HH Investments VC | Central Region, Singapore, Singapore |
| Hongxin Lianhua Venture Capital | China, Guangdong, Shenzhen |
| Howell Capital | California, San Francisco, United States |
| i-tracing | - |
| Illion | - |
| Kaijia Capital | - |
| MRV Communications | California, Chatsworth, United States |
| MTN | Gauteng, Johannesburg, South Africa |
| OKS Group | Luxembourg, Luxembourg |
| RATTG Verwaltungs | - |
| Red Sky Capital Management | Canada, Ontario, Toronto |
| SFINE | France, Ile-de-France, Montgeron |
| Silicon Laboratories | Austin, Texas, United States |
| STIC Ventures | Seoul, Seoul-t'ukpyolsi, South Korea |
| Tenshi Life Sciences | - |
| The Boeing Company | Chicago, Illinois, United States |
| The Home Depot | Atlanta, Georgia, United States |
| VinaCapital Ventures | Chicago, Illinois, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
Portola Pharmaceuticals | $70M | 07 May 2007 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $60M | 01 Jul 2008 | South San Francisco, California, United States | ||
Portola Pharmaceuticals | $70M | 07 May 2007 | South San Francisco, California, United States |
